Platinum (IV) complexes
    5.
    发明授权
    Platinum (IV) complexes 失效
    铂(IV)配合物

    公开(公告)号:US4845124A

    公开(公告)日:1989-07-04

    申请号:US20893

    申请日:1987-03-02

    CPC分类号: C07F15/0093

    摘要: New platinum (IV) complexes are now provided, which exhibit antitumor activity as shown by the tests on mouse leukemia, L-1210 cell in mice. These new platinum (IV) complexes contain 1,2-cyclohexanediamine or 2-(aminomethyl)cyclohexyl-amine as a ligand.

    摘要翻译: 现在提供了新的铂(IV)配合物,其显示抗小鼠活性,如小鼠白血病,L-1210细胞在小鼠中的测试所示。 这些新的铂(IV)络合物含有1,2-环己二胺或2-(氨基甲基)环己基 - 胺作为配体。

    Cytostatic platinum organic complexes
    8.
    发明授权
    Cytostatic platinum organic complexes 失效
    细胞活性铂有机配合物

    公开(公告)号:US4710577A

    公开(公告)日:1987-12-01

    申请号:US637463

    申请日:1984-08-03

    摘要: 1,2-Diaminocyclohexane platinum (II) complexes of the general formula: ##STR1## wherein R.sub.1 and R.sub.2, are selected from nitrate and various organic carboxylate groups, with the proviso that R.sub.1 and R.sub.2 are not both nitrate, and the configuration of the 1,2-diaminocyclohexane being selected from cis, trans-d and trans-1, have been found to exhibit potent cytostatic activity.They may be made by reacting a starting material, in which R.sub.1 and R.sub.2 are nitrate, with the appropriate carboxylic acid or salt thereof.

    摘要翻译: 具有以下通式的1,2-二氨基环己烷铂(II)络合物:其中R1和R2选自硝酸盐和各种有机羧酸盐基团,条件是R 1和R 2不是硝酸盐,并且 已经发现,选自顺式,反式和反式-1的1,2-二氨基环己烷的构型表现出有效的细胞生长抑制活性。 它们可以通过使其中R1和R2是硝酸根的原料与合适的羧酸或其盐反应来制备。

    Complex compounds of platinum
    9.
    发明授权
    Complex compounds of platinum 失效
    铂复合物

    公开(公告)号:US4567285A

    公开(公告)日:1986-01-28

    申请号:US753537

    申请日:1985-07-10

    IPC分类号: C07F15/00

    CPC分类号: C07F15/0093

    摘要: Disclosed herein are novel complex compounds of platinum showing an antitumor activity, represented by the formula(I): ##STR1## wherein one of R.sup.1 and R.sup.2 represents a group selected from the group consisting of (1) glucuronato groups whose hydroxyl groups may be acylated, (2) gluconato groups whose hydroxyl groups may be acylated, (3) pyruvato group and (4) nitrato group, and the other of R.sup.1 and R.sup.2 represents a group selected from the group consisting of (i) glucuronato groups whose hydroxyl groups may be acylated, (ii) gluconato groups whose hydroxyl groups may be acylated, (iii) pyruvato group and (iv) halogen atoms, or R.sup.1 and R.sup.2 represent together the group represented by the formula(II): ##STR2##

    摘要翻译: 本文公开了显示抗肿瘤活性的铂的新型复合化合物,其由式(I)表示:其中R 1和R 2之一表示选自以下的基团:(1)葡糖醛酸基,其羟基 可以被酰化,(2)可以酰化羟基的葡糖酸基,(3)丙酮酸基和(4)硝基,另一个R 1和R 2表示选自以下的基团:(i)葡糖醛酸基 羟基可以被酰化,(ii)其羟基可被酰化的葡萄糖酸基团,(iii)丙酮酸基和(iv)卤素原子,或者R 1和R 2一起表示由式(II)表示的基团:( 二)